Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.
<h4>Background</h4>Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age. Therefore, pneumococcal diseases prevention became a public health priorit...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24905093/pdf/?tool=EBI |
| _version_ | 1819180958997282816 |
|---|---|
| author | María Hortal Miguel Estevan Miguel Meny Inés Iraola Hilda Laurani |
| author_facet | María Hortal Miguel Estevan Miguel Meny Inés Iraola Hilda Laurani |
| author_sort | María Hortal |
| collection | DOAJ |
| description | <h4>Background</h4>Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age. Therefore, pneumococcal diseases prevention became a public health priority. Uruguay was the first Latin American country to incorporate PCV7 into its National Immunization Program. The aim of this study is to compare the incidence rates for hospitalized pneumonia in children from the pre PCV introduction period and the following five years of PCVs application in Uruguay.<h4>Methods and findings</h4>Population-based surveillance of pneumonia hospitalization rates, in children, less than 14 years of age, had been performed prior pneumococcal vaccination, and continued following PCV7 introduction and PCV13 replacement, using the same methodology. Hospitalized children with pneumonia were enrolled from January 1, 2009 through December 31st, 2012. The study was carried out in an area with a population of 238,002 inhabitants of whom 18, 055 were under five years of age. Patients with acute lower respiratory infections for whom a chest radiograph was performed on admission were eligible. Digitalized radiographs were interpreted by a reference radiologist, using WHO criteria. Pneumonia was confirmed in 2,697 patients, 1,267 with consolidated and 1,430 with non consolidated pneumonia of which incidence decrease, between 2009 and 2012, was 27.3% and 46.4% respectively. 2001-2004 and 2009-2012 comparison showed a significant difference of 20.4% for consolidated pneumonia hospitalizations. A significant incidence decline was recorded among children 6 to 35 months of age.<h4>Conclusions</h4>An overall significant reduction in pneumonia hospitalizations was observed following the introduction of PCV7 and furthermore following the change to PCV13. |
| first_indexed | 2024-12-22T22:22:37Z |
| format | Article |
| id | doaj.art-47fb8dafed1e4c4395be0da2758d27b1 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T22:22:37Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-47fb8dafed1e4c4395be0da2758d27b12022-12-21T18:10:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e9856710.1371/journal.pone.0098567Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.María HortalMiguel EstevanMiguel MenyInés IraolaHilda Laurani<h4>Background</h4>Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age. Therefore, pneumococcal diseases prevention became a public health priority. Uruguay was the first Latin American country to incorporate PCV7 into its National Immunization Program. The aim of this study is to compare the incidence rates for hospitalized pneumonia in children from the pre PCV introduction period and the following five years of PCVs application in Uruguay.<h4>Methods and findings</h4>Population-based surveillance of pneumonia hospitalization rates, in children, less than 14 years of age, had been performed prior pneumococcal vaccination, and continued following PCV7 introduction and PCV13 replacement, using the same methodology. Hospitalized children with pneumonia were enrolled from January 1, 2009 through December 31st, 2012. The study was carried out in an area with a population of 238,002 inhabitants of whom 18, 055 were under five years of age. Patients with acute lower respiratory infections for whom a chest radiograph was performed on admission were eligible. Digitalized radiographs were interpreted by a reference radiologist, using WHO criteria. Pneumonia was confirmed in 2,697 patients, 1,267 with consolidated and 1,430 with non consolidated pneumonia of which incidence decrease, between 2009 and 2012, was 27.3% and 46.4% respectively. 2001-2004 and 2009-2012 comparison showed a significant difference of 20.4% for consolidated pneumonia hospitalizations. A significant incidence decline was recorded among children 6 to 35 months of age.<h4>Conclusions</h4>An overall significant reduction in pneumonia hospitalizations was observed following the introduction of PCV7 and furthermore following the change to PCV13.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24905093/pdf/?tool=EBI |
| spellingShingle | María Hortal Miguel Estevan Miguel Meny Inés Iraola Hilda Laurani Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. PLoS ONE |
| title | Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. |
| title_full | Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. |
| title_fullStr | Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. |
| title_full_unstemmed | Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. |
| title_short | Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay. |
| title_sort | impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in uruguay |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24905093/pdf/?tool=EBI |
| work_keys_str_mv | AT mariahortal impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay AT miguelestevan impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay AT miguelmeny impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay AT inesiraola impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay AT hildalaurani impactofpneumococcalconjugatevaccinesontheincidenceofpneumoniainhospitalizedchildrenafterfiveyearsofitsintroductioninuruguay |